Personal information

No personal information available

Activities

Employment (1)

Universidad de Buenos Aires Facultad de Farmacia y Bioquimica: Buenos Aires, AR

2007-03-10 to present | Full Profesor (Clinical Biochemistry)
Employment
Source: Self-asserted source
Alberto Lazarowski

Education and qualifications (5)

Universidad de Buenos Aires Facultad de Farmacia y Bioquimica: Buenos Aires, AR

2016-03-07 to 2018-10-24 | Biochemistry Specialist in Hematology (Postgraduate)
Education
Source: Self-asserted source
Alberto Lazarowski

Universidad Favaloro: Buenos Aires, AR

2000-09-30 to 2001-10-19 | Master in Molecular Biology and Genetic engineering (Postgraduate)
Education
Source: Self-asserted source
Alberto Lazarowski

Universidad de Buenos Aires Facultad de Farmacia y Bioquimica: Buenos Aires, AR

1984-03-18 to 1988-11-18 | PhD (Postgraduate)
Education
Source: Self-asserted source
Alberto Lazarowski

Universidad de Buenos Aires Facultad de Farmacia y Bioquimica: Buenos Aires, AR

1973-03-03 to 1980-11-18 | Biochemical (Biochemistry)
Education
Source: Self-asserted source
Alberto Lazarowski

Universidad de Buenos Aires Facultad de Farmacia y Bioquimica: Buenos Aires, AR

1979-03-12 to 1980-09-17 | Licenciatura en uso de Radioisótopos (Radiochemicstry)
Education
Source: Self-asserted source
Alberto Lazarowski

Professional activities (32)

Asociación Química Argentina: Buenos Aires, AR

2016-08-11 to present | Full Member (Comisión Directiva)
Membership
Source: Self-asserted source
Alberto Lazarowski

Liga Argentina Contra la Epilepsia: Buenos Aires, AR

2016-04-14 to present | Full Member
Membership
Source: Self-asserted source
Alberto Lazarowski

Sociedad Argentina deInvestigacion Clínica: Buenos Aires, AR

1987-10-12 to present | Full Member
Membership
Source: Self-asserted source
Alberto Lazarowski

Sociedad Argentina de Hematología: Buenos Aires, AR

1983-02-18 to present | Full member
Service
Source: Self-asserted source
Alberto Lazarowski

Asociación Química Argentina: Buenos Aires, AR

2019-03-15 | Mejor trabajo en el área Bioquímica Clínica. “Uridina-Difosfato-Glucosa (UDP-G) activa el estallido respiratorio y el estrés oxidativo en polimorfonucleares neutrófilos (XXXII Congreso AQA)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Universidad de Buenos Aires: Buenos Aires, AR

2016-10-25 | Mención Académica por reconocimiento recibido en 2015 (Rectorado)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Asociación Química Argentina: Buenos Aires, AR

2015-11-26 | Premio “Dr Federico Leloir”, a la Trayectoria en el área de la Bioquímica y Biotecnología
Distinction
Source: Self-asserted source
Alberto Lazarowski

Universidad de Buenos Aires: Buenos Aires, AR

2015-11-04 | Mención Académica por reconocimiento recibido en 2014 (rectorado)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Consejo Ejecutivo Superior del Colegio de Bioquímica y Farmacia de Bolivia: Beni, BO

2015-05-30 | Reconocimiento: “Profesionales Bioquímicos y Farmacéuticos gestores del Cambio”
Distinction
Source: Self-asserted source
Alberto Lazarowski

Sociedad Argentina de Hematología: Buenos Aires, AR

2014-02-10 to 2015-02-10 | Full member (Scientific Comittee )
Membership
Source: Self-asserted source
Alberto Lazarowski

Sociedad Mexicana de Neurología Pediátrica: Mérida, MX

2014-05-20 | Reconocimiento. Por su invaluable aporte científico y personal en el desarrollo y fortalecimiento de la neurología pediátrica mexicana
Distinction
Source: Self-asserted source
Alberto Lazarowski

Sociedad Chilena de Neurofisiología Clínica: Santiago, CL

2013-12-06 | Miembro Honorario
Distinction
Source: Self-asserted source
Alberto Lazarowski

Curso Internacional “Bioquímicos y Farmacéuticos Gestionando Calidad”.: Sucre, BO

2013-08-15 | Distinción Especial Colegio de Bioquímia y Farmacia de Bolivia (Colegio de Bioquímia y Farmacia de Bolivia)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Sociedad Argentina de Hematología: Buenos Aires, AR

2009-01-02 to 2011-12-30 | Vocal Titular (Comisión Directiva)
Membership
Source: Self-asserted source
Alberto Lazarowski

Sociedad Argentina de Hematología: Buenos Aires, AR

2009-02-03 to 2011-12-10 | Full member (Board of Education member)
Membership
Source: Self-asserted source
Alberto Lazarowski

III Simposio Mundial Avances en Flebología y Linfografía.: Buenos Aires, Select, AR

2011-10-20 | Premio Mejor Presentación: Estudio de las acciones y efectos de la aplicación de lactoferina gel en pacientes condiscromía hemosiderínica y úlcera asociadas. Estudio Piloto-2011
Distinction
Source: Self-asserted source
Alberto Lazarowski

Sociedad Argentina de Hematología: Buenos Aires, AR

2011-10-06 | Mejor Poster en Hematología Experimental Trabajo: Efecto tóxico-inhibitorio de artemisinina sobre la eritropoyesis espon- tánea y estimulada con eritropoyetina recombinante humana en ratones sanos. (XX Congreso SAH)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Ministerio de Salud: Lima, PE

2009-10-29 | Distinción Especial, 309 Aniversario (Instituto Especializado de Ciencias Neurológicas)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Sociedad Epileptología de Chile: Santiago, CL

2009-10-16 | Miembro Honorario
Distinction
Source: Self-asserted source
Alberto Lazarowski

Universidad de Buenos Aires: Buenos Aires, AR

2008-10-16 | Distinción por el Reconocimiento recibido durante 2007 (Rectorado)
Distinction
Source: Self-asserted source
Alberto Lazarowski

CASLAN: Mendoza, AR

2008-05-29 | Primer Premio del Área de Medicina (Congr. Int. de Alimentos en el Siglo XXI. Avances en Latinoamérica. XXXI Reunión anual de CASLAN.)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Sociedad Argentina de Hematología: Buenos Aires, AR

2007-10-24 | Premio: “Dr. Alfredo Macchi”, Trabajo: “La administración de eritropoyetina intranasal preserva la actividad motora espontánea sin efecto eritropoyético en un modelo experimental de Stroke” (XVIII Congreso SAH)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Sociedad Argentina de Hematología: Buenos Aires, AR

2005-10-23 | Mejor Trabajo en Hematología Básica. Trabajo: “Gen MDR1 y resistencia al Imatinib en células K562”. (XVII Congreso SAH)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Sociedad Argentina de Neurología Infantil (SANI): Buenos Aires, Select, AR

2003-11-04 | Premio XXIII Congreso, Tema: “Expresión neuronal transitoria del gen MDR-1 en un modelo de hipoxia cerebral debida a desvascularización cortical focal”. (XXIII Congreso)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Honorable Cámara de Diputados de la Nación: Buenos Aires, Select, AR

2003-10-20 | Expresión de Beneplácito y Felicitación a Científicos Destacados del año 2002. (Comisión de Ciencia y Técnica.)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Academia Nacional de Medicina: Buenos Aires, Buenos Aires, AR

2002-11-16 | “Elsa Arini de Masnata: Radioisótopos en Hematología” Tema:“Evaluación de la respuesta a la quimioterapia con el uso de la captación centellográfica de 99mTc-SESTAMIBI en linfomas y su utilización en la predicción de quimio-sensibilidad”. (Hematology)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Sociedad Argentina de Neurologia Infantil (SANI): Buenos Aires, Select, AR

2002-10-18 | Premio XXII Congreso- Tema: “Proteinas de resistencia multiple a drogas MDR-1 y MRP-1 en Esclerosis Tuberosa y Epilepsia Refractaria”. (XXII Congrso Argentino de SANI)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Asociación Bioquímica Argentina: Buenos Aires, Select, AR

1999-10-09 | Premio al Mejor Trabajo Clínico: "Tema:"Niveles de drogas antiepilépticas en saliva como indicador de niveles de droga libre en plasma en 14 niños". (63 Congreso)
Distinction
Source: Self-asserted source
Alberto Lazarowski

International Child Neurology Association (ICNA): Montevideo, UY

1998-09-18 | Valcote Adward: "Niveles subterapéuticos de AEDs y fenotipo MDR positivo en un niño con Epilepsia Refractaria y crisis subintrantes" (2nd educational seminar)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Asociación Argentina de Biología y medicina Nuclear: Buenos Aires, Select, AR

1996-10-19 | Premio Congreso AAByMN "Estudio Dinámico Esplénico en pacientes anémicos y trombocitopénicos"
Distinction
Source: Self-asserted source
Alberto Lazarowski

Asociación Médica Argentina: Buenos Aires, Select, AR

1996-09-17 | Premio "J. Aranovich". Trabajo: “Uso profiláctico de Difenilhidantoína (EPAMIN) en procedimientos neuroquirúrgicos depacientes no epilépticos. Existe diferencia en relación al tiempo y vía de administración?” (Asociación Argentina de Neurociencias)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Academia Nacional de Medicina: Buenos Aires, Buenos Aires, AR

1990-11-10 | Premio Bienal de la Acad. Nac. de Medicina:“Elsa Arini de Masnata: Radioisótopos en Hematología”. Trabajo: “Estudio Dinámico Esplénico con cámara gamma en citopenias hematológicas” (Hematology)
Distinction
Source: Self-asserted source
Alberto Lazarowski

Works (50 of 52)

Items per page:
Page 1 of 2

Enlightening the Mechanism of Ferroptosis in Epileptic Heart

Current Medicinal Chemistry
2024-03 | Journal article
Contributors: Enes Akyüz; Qamar Hakeem Saleem; Çiğdem Sari; Jerónimo Auzmendi; Alberto Lazarowski
Source: check_circle
Crossref

COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved

Current Medicinal Chemistry
2023-10 | Journal article
Contributors: Alicia B. Pomilio; Arturo A. Vitale; Alberto J. Lazarowski
Source: check_circle
Crossref

Uridine Diphosphate Glucose (UDP-G) Activates Oxidative Stress and Respiratory Burst in Isolated Neutrophils

Pharmaceuticals
2023-10-21 | Journal article
Contributors: Fabiana Lairion; Claudio Carbia; Iris Maribel Chiesa; Christian Saporito-Magriña; Natalia Borda; Alberto Lazarowski; Marisa Gabriela Repetto
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?

Epilepsia Open
2022-08 | Journal article
Contributors: Liliana Czornyj; Jerónimo Auzmendi; Alberto Lazarowski
Source: check_circle
Crossref

Neuroproteomics Chip-Based Mass Spectrometry and Other Techniques for Alzheimer’s Disease Biomarkers – Update

Current Pharmaceutical Design
2022-04 | Journal article
Contributors: Alicia B. Pomilio; Arturo A. Vitale; Alberto J. Lazarowski
Source: check_circle
Crossref

Uncommon Noninvasive Biomarkers for the Evaluation and Monitoring of the Etiopathogenesis of Alzheimer's Disease

Current Pharmaceutical Design
2022-04 | Journal article
Contributors: Alicia B. Pomilio; Arturo A. Vitale; Alberto J. Lazarowski
Source: check_circle
Crossref

Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment

Pharmaceuticals
2021-03-05 | Journal article
Contributors: Claudia Taborda Gómez; Fabiana Lairion; Marisa Repetto; Miren Ettcheto; Amalia Merelli; Alberto Lazarowski; Jerónimo Auzmendi
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Supplementation with Resveratrol, Piperine and Alpha-Tocopherol Decreases Chronic Inflammation in a Cluster of Older Adults with Metabolic Syndrome

Nutrients
2020-10-15 | Journal article
Contributors: Raúl Francisco Pastor; Marisa Gabriela Repetto; Fabiana Lairion; Alberto Lazarowski; Amalia Merelli; Zulma Manfredi Carabetti; Isabel Pastor; Elena Pastor; Laura Valeria Iermoli; Carlos Amadeo Bavasso et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

EPO and EPO-Receptor System as Potential Actionable Mechanism for the Protection of Brain and Heart in Refractory Epilepsy and SUDEP

Current Pharmaceutical Design
2020-05-06 | Journal article
Contributors: Jerónimo Auzmendi; María B. Puchulu; Julio C. G. Rodríguez; Ana M. Balaszczuk; Alberto Lazarowski; Amalia Merelli
Source: check_circle
Crossref

Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?

Epilepsia Open
2020-03 | Journal article
Contributors: Luisa Rocha; Christian Lizette Frías‐Soria; José G. Ortiz; Jerónimo Auzmendi; Alberto Lazarowski
Source: check_circle
Crossref

Metastatic Niches and the Modulatory Contribution of Mesenchymal Stem Cells and Its Exosomes.

International journal of molecular sciences
2019-04-20 | Journal article
Source: Self-asserted source
Alberto Lazarowski
grade
Preferred source (of 2)‎

High incidence of persistent subtherapeutic levels of the most common AEDs in children with epilepsy receiving polytherapy.

Epilepsy research
2018-09-22 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Pilocarpine-Induced Status Epilepticus Is Associated with P-Glycoprotein Induction in Cardiomyocytes, Electrocardiographic Changes, and Sudden Death.

Pharmaceuticals (Basel, Switzerland)
2018-02-16 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities.

Current neuropharmacology
2018-01-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Role of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegeneration.

Frontiers in bioscience (Landmark edition)
2017-01-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant Patients.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
2015-10-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Twenty-One Novel EGFR Kinase Domain variants in Patients with Nonsmall Cell Lung Cancer.

Annals of human genetics
2015-09-29 | Journal article
Source: Self-asserted source
Alberto Lazarowski

MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia.

Blood research
2015-09-22 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Masitinib for the treatment of mild to moderate Alzheimer's disease.

Expert review of neurotherapeutics
2015-05-11 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases.

The International journal of neuroscience
2015-01-09 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Mavoglurant as a treatment for Parkinson's disease.

Expert opinion on investigational drugs
2014-06-24 | Journal article
Source: Self-asserted source
Alberto Lazarowski

ABC-transporters as stem-cell markers in brain dysplasia/tumor epilepsies.

Frontiers in bioscience (Landmark edition)
2014-06-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Pharmacoresistant epilepsy and nanotechnology.

Frontiers in bioscience (Elite edition)
2014-06-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Genetic variants in C5 and poor response to eculizumab.

The New England journal of medicine
2014-02-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Evaluation of hypoxia inducible factor expression in inflammatory and neurodegenerative brain models.

The international journal of biochemistry & cell biology
2013-04-17 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Erythropoietin: a neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsy.

Current pharmaceutical design
2013-01-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

P-glycoprotein contributes to cell membrane depolarization of hippocampus and neocortex in a model of repetitive seizures induced by pentylenetetrazole in rats.

Current pharmaceutical design
2013-01-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.

Current pharmaceutical design
2013-01-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia.

Drug metabolism and drug interactions
2011-07-14 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions.

Drug metabolism and drug interactions
2011-01-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats.

Neurotoxicity research
2010-11-30 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Intermittent hypoxia during sleep induces reactive gliosis and limited neuronal death in rats: implications for sleep apnea.

Journal of neurochemistry
2009-12-10 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Neuronal and glial alterations due to focal cortical hypoxia induced by direct cobalt chloride (CoCl2) brain injection.

Neurotoxicity research
2009-03-20 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Differential hippocampal pharmacokinetics of phenobarbital and carbamazepine in repetitive seizures induced by 3-mercaptopropionic acid.

Neuroscience letters
2009-02-04 | Journal article
Source: Self-asserted source
Alberto Lazarowski

P-glycoprotein--a clinical target in drug-refractory epilepsy?

Molecular pharmacology
2008-02-26 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Neuronal mdr-1 gene expression after experimental focal hypoxia: a new obstacle for neuroprotection?

Journal of the neurological sciences
2007-04-24 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic model.

Neuroscience letters
2007-01-08 | Journal article
Source: Self-asserted source
Alberto Lazarowski

ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.

Epilepsia
2007-01-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Expression of the MDR-1 gene-encoded P-glycoprotein in cardiomyocytes of conscious sheep undergoing acute myocardial ischemia followed by reperfusion.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
2006-11-13 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Multidrug resistance gene (MDR-1) expression in the colonic mucosa of patients with refractory ulcerative colitis.

Acta gastroenterologica Latinoamericana
2006-03-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

99mTechnetium-SESTAMIBI uptake in malignant lymphomas. Correlation with chemotherapy response.

Lymphatic research and biology
2006-01-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

New proteins configure a brain drug resistance map in tuberous sclerosis.

Pediatric neurology
2006-01-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Cardiomyocytes of chronically ischemic pig hearts express the MDR-1 gene-encoded P-glycoprotein.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
2005-07-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy.

Pediatric neurology
2004-02-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.

Cellular and molecular neurobiology
2004-02-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Neuronal MDR-1 gene expression and persistent low levels of anticonvulsants in a child with refractory epilepsy.

Therapeutic drug monitoring
2004-02-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Transient expression of MDR-1/P-glycoprotein in a model of partial cortical devascularization.

Cellular and molecular neurobiology
2004-02-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Cerebral arteritis following methylphenidate use.

Journal of child neurology
2000-04-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy.

Pediatric neurology
1999-10-01 | Journal article
Source: Self-asserted source
Alberto Lazarowski

Use of antiepileptic drugs in nontraumatic neurosurgical procedures. Is there any best route and time of administration?

Clinical neuropharmacology
1997-10-01 | Journal article
PMID: 9331520
Source: Self-asserted source
Alberto Lazarowski
Items per page:
Page 1 of 2

Peer review (9 reviews for 6 publications/grants)

Review activity for Biological trace element research. (2)
Review activity for Cellular and molecular life sciences (1)
Review activity for Cellular and molecular neurobiology. (2)
Review activity for EBioMedicine. (1)
Review activity for Epilepsy & behavior. (1)
Review activity for Neuropharmacology. (2)